Publications by authors named "Cristiano Ferrario"

23 Publications

  • Page 1 of 1

Metastatic Breast Carcinoma-Associated Fibroblasts Have Enhanced Protumorigenic Properties Related to Increased IGF2 Expression.

Clin Cancer Res 2019 12 12;25(23):7229-7242. Epub 2019 Sep 12.

Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Canada.

View Article and Find Full Text PDF
December 2019

Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review.

Oncol Lett 2015 Aug 5;10(2):773-777. Epub 2015 Jun 5.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola (FC), Italy.

View Article and Find Full Text PDF
August 2015

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer.

Breast Cancer Res Treat 2015 Jul 27;152(1):57-65. Epub 2015 May 27.

Department of Medical Oncology, Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via Piero Maroncelli 40, 47014, Meldola, Italy.

View Article and Find Full Text PDF
July 2015

Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary.

BMJ Case Rep 2014 Jun 12;2014. Epub 2014 Jun 12.

Department of Medical Oncology, Jewish General Hospital, Montreal, Quebec, Canada.

View Article and Find Full Text PDF
June 2014

Advances in the approach to novel drug clinical development for breast cancer.

Expert Opin Drug Discov 2014 Jun 23;9(6):647-68. Epub 2014 Apr 23.

McGill University, Jewish General Hospital, Segal Cancer Centre, Department of Oncology , 3755 Cote Ste Catherine Rd. W, Montreal, Quebec H3T1E2 , Canada

View Article and Find Full Text PDF
June 2014

The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.

BMC Med Genomics 2011 Jan 27;4:16. Epub 2011 Jan 27.

Department of Oncology, Lady Davis Institute, Sir Mortimer B, Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

View Article and Find Full Text PDF
January 2011

The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.

Am J Pathol 2009 Jul 4;175(1):66-73. Epub 2009 Jun 4.

Department of Oncology, Lady Davis Institute, Sir Mortimer B Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.

View Article and Find Full Text PDF
July 2009

Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.

Breast Cancer Res Treat 2010 Feb 20;120(1):47-57. Epub 2009 Mar 20.

Department of Oncology and Surgery, Segal Cancer Center, Sir Mortimer B. Davis Jewish General Hospital, 3755 Cote Ste Catherine, Montreal, QC, H3T 1E2, Canada.

View Article and Find Full Text PDF
February 2010

Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.

Br J Haematol 2008 Dec;143(5):698-706

Lady Davis Institute for Medical Research-Cancer Segal Center, Sir MB Davis-Jewish General Hospital, Montreal, Canada

View Article and Find Full Text PDF
December 2008

Tissue microarrays: emerging standard for biomarker validation.

Curr Opin Biotechnol 2008 Feb 3;19(1):19-25. Epub 2007 Dec 3.

Departments of Oncology and Surgery, Segal Cancer Center, 3755 Cote Ste Catherine Road, Montreal, Quebec, Canada H3T 1E2.

View Article and Find Full Text PDF
February 2008

Microarrays as validation strategies in clinical samples: tissue and protein microarrays.

OMICS 2006 ;10(3):311-26

Montreal Center for Experimental Therapeutics in Cancer, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis-Jewish General Hospital, and Department of Oncology, McGill University and Surgery, Montreal, Canada.

View Article and Find Full Text PDF
December 2006